Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

48.95
Delayed Data
As of Apr 29
 -1.58 / -3.13%
Today’s Change
33.50
Today|||52-Week Range
126.35
-24.60%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Higgons John Duncan
Chief Operating Officer
Sale7/16/201520,000$114.02$2.3M-57.54%
Higgons John Duncan
Chief Operating Officer
Sale8/17/201520,000$92.24$1.8M-49.08%
Higgons John Duncan
Chief Operating Officer
Sale9/15/201520,000$91.11$1.8M-46.91%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale7/17/201513,000$113.71$1.5M-57.33%
Higgons John Duncan
Chief Operating Officer
Sale10/15/201520,000$71.04$1.4M-35.94%
Higgons John Duncan
Chief Operating Officer
Sale11/16/201520,000$61.51$1.2M-17.22%
Schenkein David Paul
Chief Executive Officer
Sale5/27/20158,929$120.05$1.1M-60.28%
Higgons John Duncan
Chief Operating Officer
Sale12/15/201520,000$50.09$1.0M-3.13%
Schenkein David Paul
Chief Executive Officer
Sale8/03/20158,000$110.60$884.8K-55.87%
Goddard Glenn /archemix/
Senior Vice President-Finance
Sale7/23/20157,000$120.45$843.2K-58.66%
Page of 13